Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-21
1996-01-02
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548200, 548205, A01N 4378, C07D27724, C07D27728
Patent
active
054808979
ABSTRACT:
The use of nicotinic anilide derivatives of the general formula ##STR1## where the substituents have the following meanings: R.sup.1 halogen, methyl, trifluoromethyl, methoxy, methylthio, methylsulfinyl, methylsulfonyl
REFERENCES:
patent: 3709992 (1973-01-01), von Schneling et al.
patent: 3725427 (1973-04-01), Harrison et al.
patent: 3883658 (1975-05-01), Phillips et al.
patent: 4153703 (1979-05-01), Harrison et al.
patent: 4427688 (1984-01-01), Rentzen et al.
patent: 4837242 (1989-06-01), Ohsumi et al.
patent: 4877802 (1989-10-01), Wilson et al.
patent: 4992434 (1991-02-01), Topfl et al.
patent: 5045554 (1991-09-01), Alt et al.
Ammermann Eberhard
Eicken Karl
Goetz Norbert
Harreus Albrecht
Lorenz Gisela
BASF - Aktiengesellschaft
Lambkin Deborah
Raymond Richard L.
LandOfFree
Anilide derivatives and their use for combating botrytis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anilide derivatives and their use for combating botrytis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anilide derivatives and their use for combating botrytis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-235438